chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by an attorney and described the occurrence of mercury poisoning in a 33 month old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed and hepatitis B vaccine for prophylaxis. The attorney stated that by 7/25/01, the child was exposed to levels of toxic mercury exceeding the allowable levels of mercury exposure. The child has been diagnosed with severe autism. This report was received via the litigation process and a physician or other health care professional has not verified the report. On 7/25/01 the patient received Infanrix, which was administered as the fourth dose in the DTaP immunization series. Co-administered vaccinations between 3/17/00 and 7/25/01 were the following: the patient received injections of inactivated poliomyelitis virus vaccine. He also received hepatitis B vaccine, diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed, haemophilus influenzae type B conjugate vaccine, and MMR virus vaccine. (Note: the hepatitis Bvaccine was administered on a 0, 2, and 4 month schedule rather than the recommended schedule of 0, 1, and 6 months.). On 10/2/02, the patient was diagnosed with severe autism. This case was assessed as medically serious (OMIC). The attorney stated that the child sustained and will sustain in the future a mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments. The most recent informatiion, received on 04AUG204, identified the vaccine that had been administered.
Patient was seen in our office for his 1 year well child visit. Patient was due for HIB and PCV13. Hib we have in stock needs to be reconstituted with Saline Diluent (0.4% Sodium Chloride). Instead this vaccine was reconstituted with 0.7 mL Sterile Diluent (sterile water). Per Health Department patient needs to be re-vaccinated as dose will be invalid. Mother of patient states patient developed a fever last night but she has been alternating tylenol and ibuprofen. Patient's fever has subsided. Spoke with Mother and patients symptoms have subsided and patient seems to be doing better. Patient is scheduled for a nurse visit to be re-vaccinated on 07/13/21.
Nearing 24 hours after receiving my second  vaccine, I began to feel ill, similar to an intestinal flu coming on, weak and dizzy.  I felt that way for approximately 20 minutes and went lie down but began to feel more dizzy and then very nauseated.  I then vomited several times and afterward began to feel steadily better.  The whole even was approximately 2 hour before I felt back to normal.
Headache, Arthralgia, Diarrhea, Chills, Flu-like Symptoms Narrative:  No further details given
C/o: Pain radiating down arm to elbow and up into neck and side of face. 10-7-10 to 11-4-10.
UrticariaPruritus Puritic, erythematous, painful induration 9x6 cm  Narrative:  immed induration , resolved then recurred to 9x6cm red and painful.
About 15 hours after receiving the vaccine I woke up to having chills, uncontrollable shaking, fever, headache, muscle and joint pain that was so severe I could hardly walk or stand.  I then started to vomit every 15 minutes for the next two days and could not stop.  I called my doctors office and was told to call 911 immediately and go to the emergency room.
Subsequent to receiving one dose of varicella virus vaccine live, the pt developed approximately 30 - 35 itchy lesions on her neck, ankle, back and stomach that have not crusted over. Pt was treated with Caladryl and oatmeal baths.
Information has been received from an investigator concerning a 51 year old male who received placebo for influenza virus vaccine, trivalent, types A & B, live cold adapted (frozen)(nasal solution) along with 1998-99 formula inactivated influenza virus vaccine (mfr unk) on 11/4/98 as part of a clinical trial. The pt experienced a mild exacerbation of chronic obstructive airways disease and was hospitalized. The subject also stated his post traumatic stress disorder was acting up and if he was not admitted to the hospital at that time, he may kill himself. The investigator felt the exacerbation of chronic obstructive airways disease was "possibly related" to study product or concomitant vaccine administration. The medical monitor's assessment was unknown.
2/22/2021- Moderna 030L20A  2/22/2021-Moderna 013M20A 90 years old woman who came with generalized weakness, bilateral lower extremity edema.  The patient has been having pitting lower extremity edema.  She was sent to the ER for worsening refractory lower extremity edema.   Continue with IV Decadron 6 mg IV daily Oxygen supplementation as needed
Soreness; I have a headache; On the second day I had face warm arm; Arm pain; 30 minutes after I received the vaccine I started feeling dizzy and after I got home the dizziness got worse; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (30 minutes after I received the vaccine I started feeling dizzy and after I got home the dizziness got worse), PAIN (Soreness), VACCINATION SITE WARMTH (On the second day I had face warm arm), VACCINATION SITE PAIN (Arm pain) and HEADACHE (I have a headache) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053B21A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 15-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Aug-2021, the patient experienced DIZZINESS (30 minutes after I received the vaccine I started feeling dizzy and after I got home the dizziness got worse). On 16-Aug-2021, the patient experienced VACCINATION SITE WARMTH (On the second day I had face warm arm) and VACCINATION SITE PAIN (Arm pain). On 19-Aug-2021, the patient experienced PAIN (Soreness) and HEADACHE (I have a headache). At the time of the report, DIZZINESS (30 minutes after I received the vaccine I started feeling dizzy and after I got home the dizziness got worse), PAIN (Soreness), VACCINATION SITE WARMTH (On the second day I had face warm arm), VACCINATION SITE PAIN (Arm pain) and HEADACHE (I have a headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information not provided by reporter.  Patient received her first dose of the Moderna COVID-19 vaccine on 15AUG2021 in the left nondominant arm lot number 053B21A expiration date unknown. The patient reports that after receiving the vaccine she started to experience dizziness, headache, arm pain and soreness. The symptoms are currently ongoing.
Approximately 3 inch round red area around injection site, heat at redness, a little tender, small clear fluid filled bump at apparent injection site.
Extreme dizziness (1/6/22 onset, lasting for hours at a time) Back pain (7/10 pain scale, 1/4/22 onset, lasting for 3 days) UTI (asymptomatic, unknown onset, prescribed cephalexin for 7 days)  Determined that the dizziness was from starting buspirone on 1/1/22 immediately after stopping Zoloft. Patient instructed to stop buspirone and restart Zoloft on 1/6/22. Back pain was attributed to PMS.
This spontaneous report as received from a Licensed Practical  Nurse refers to a patient of 12 months old infant patient and unknown gender. On 11-SEP-2014 the patient was vaccinated with a dose of (Oka/Merck) PROQUAD (lot K006771, expiration date 07-NOV-2015) (dose, route not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. The reporter also stated that as of 29-AUG-2014 they had 18 doses left of this lot number. This is one of several reports received from the same source. Additional information has been requested.
Metalic Taste and light headed after vaccine. 193/117  Given water observed for 30 minutes. 179/111, 146/89. Refused to be transported, released.
Patient was given PNEUMOVAX 23. Patient went home and a few hours later called in stating his arm had a softball size lump below the injection site. He came back to the office and we had given him ice and evaluated him. Patient was instructed to go home and take 2 BENADRYL before bedtime and put ice on the softball size lump. Patient came in the following day for follow up on injection site. Patients arm didn't have the softball size lump but the swelling had moved down the inside of his arm and was slightly red. Patient was advised to keep an eye on the swelling and if anything else became worse to go to Urgent Care over the weekend.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history and concomitant medications were reported. On 12-JUN-2015, the patient received improperly stored MMR II, injection (dose, route of administration, albumin status, lot # and expiration date were not provided). No adverse effects were reported. Additional information has been requested.
Increased temp 102, vomiting refused to walk right leg, swollen. Child started symptoms with (thigh) 6:00 on 1/21/04. 1000 11/22/04 with clinic.
Gave pt COVID vaccine yesterday morning. Was using a different syringe than normal and accidentally gave pt 1 mL instead of 0.5. Finally got a hold of the pt 2/17/21 at 3:45 pm she said her arm is sore but otherwise no side effects. Told her to call me back if she is having any issues.
Mom states that on 4/13/01, pt was very cranky and wanted to be held most of the day. Had a fever; mom did not take temperature with a thermometer but states he felt very warm. She gave him Tylenol every 4-6 hours. On 4/14/01, he woke up with a pink rash on face, arms, chest, back and legs. No fever on 4/14/01, he "even" was acting better. Rash lasted 4-5 days. Did not take child to MD because father-in-law visited and said he had the measles. He knew the rash because he had measles as an adult.
Patient was seen in rheumatology in 3-2021 with 1 month history of left arm pain in the antecubital region and polyarticular arthritis. She also was found to have multiple positive serologies polyarticular arthritis was steroid responsive Patient did take steroid sparing agents.  Has been able to wean off all medications without return of symptoms.
lymphadenopathy; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced developed lymphadenopathy 1 day after dose 2 of the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt has severe anxiety and past history of multiple reactions to medicines, psoriatic arthritis, degenerative disk issues.  She had a negative allergy test to the vaccine in my office, then was given 0.1cc x 3 in left deltoid, left glute, right deltoid - respectively. She didnt want more than 0.3ml. Next day, she had leg pain. The day after, she had a numbness from her knees, down. Third day after, she said her legs were completely "asleep". Received IV decadron and xanax at emergency room. Next day, could walk again, still had numbness and tingling. Today, she has difficulty chewing.
Swelling and painful from the elbow up to the neck Sx last 3-4 days. Patient still experiencing some very mild pain 6/28.
Pt had routine blood drawn and was given GARDASIL vaccine. While waiting to give urine specimen (standing) he passed out - hitting head on floor.
Mother reports that child cried inconsolably for 1 hr. starting at 900PM.  Infant was then lethargic & would stare into space.  Mother also felt child had difficulty swallowing - time uncertain.  Infant vomited in the night.  Mother took infant to ER 7-10-08 - AM.  According to MD office, baby did not have a fever, made good eye contact & was easily aroused from sleep.  No treatment.  Mother was very upset by incident.
PATIENT RECEIVED AN EXPIRED DOSE OF PFIZER. SHE HAD A SORE ARM.  SHE WILL BE IN TO BE REVACCINATED
Passed Out; Anxiety Attack, Upset; Received First Dose Heplisav-B, 2nd Dose Received Engerix; Initial Report Received on 26-Jun-2023  A registered pharmacist reported that his daughter, a 27-year-old female patient (race and ethnicity unknown), received a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization as the first dose, Engerix-B as the second dose, and passed out.   Medical history and concomitant medications at the time of vaccination were not reported. The patient had no known allergies.   On 23-May-2023, the patient received the first dose of HEPLISAV-B vaccine (Lot # 941591; expiration date 31-Aug-2025, NDC # 43528-003-05; route and injection site not reported).  On 24-Jun-2023, 33 days after having been vaccinated with HEPLISAV-B, the patient was given Engerix B (no details reported) as the second dose. After receiving the Engerix B vaccine, the patient passed out. The reporter believed it was due to the patient being so upset as she just started school and was worried that she would have to start the hepatitis vaccination series all over. The patient had an anxiety attack. There were no other remaining ramifications.  No additional information was provided.  Company Comment: The company assessed the events as non-serious.; Sender's Comments: The company assessed the events as non-serious.
About 5 hours after receiving influenza vaccine noticed runny nose, chills, nausea, vomiting, and diarrhea. Vomiting stopped by 03:00 10/29/05. Nauseous, diaphoretic and chills lasted 4 days. Took 1 Phenergan supp 10/08/05. Increased fluid / Gatorade. Did not seek emergency treatment.
was felling better but not that better to go to work, she can not drive her car; started having some buzzing in her ears; since one hour ago her lips started to swollen up again, and has an itchy rush all over her body; patient is afraid that her throat can close,; felt tired; body aches; nauseas; bone pain; muscles aches; flu like symptoms; After the vaccination her lips were swollen, and half of her face had some movements , that lasted for around 30-40 minutes.; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (After the vaccination her lips were swollen, and half of her face had some movements , that lasted for around 30-40 minutes.), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (was felling better but not that better to go to work, she can not drive her car), TINNITUS (started having some buzzing in her ears) and RASH PRURITIC (since one hour ago her lips started to swollen up again, and has an itchy rush all over her body) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product METHIMAZOLE for an unknown indication.    The patient's past medical history included No adverse event. Concomitant products included Quintiles Inc                                                                                                     Case and REPAGLINIDE (PAGE) for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started METHIMAZOLE (unknown route) at an unspecified dose. On 13-Mar-2021, the patient experienced LIP SWELLING (After the vaccination her lips were swollen, and half of her face had some movements , that lasted for around 30-40 minutes.). On 14-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), FATIGUE (felt tired), PAIN (body aches), NAUSEA (nauseas), BONE PAIN (bone pain) and MYALGIA (muscles aches). On 16-Mar-2021, the patient experienced MALAISE (was felling better but not that better to go to work, she can not drive her car), TINNITUS (started having some buzzing in her ears), RASH PRURITIC (since one hour ago her lips started to swollen up again, and has an itchy rush all over her body) and OROPHARYNGEAL DISCOMFORT (patient is afraid that her throat can close,). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), OROPHARYNGEAL DISCOMFORT (patient is afraid that her throat can close,), FATIGUE (felt tired), PAIN (body aches), NAUSEA (nauseas), BONE PAIN (bone pain) and MYALGIA (muscles aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
This spontaneous report was received from a Registered Nurse, concerning a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 26-JUN-2018, the patient was vaccinated with properly stored but expired PROQUAD, lot # M049122 and expiration date on 13-JUN-2018, for prophylaxis (dose, route of administration and anatomical location were not reported). The vaccine was reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT). No adverse effects were reported and no product quality complaint was involved.
The RN reported that on 08/27/2000, the patient had a fever of 103.2F. On approximately 08/28/2000, the patient experienced a varicella like rash with 100+ lesions. The patient was seen by a physician on 08/28/2000. The RN reported that on 08/28/2000, the patient had "multiple papule/pustules, red bases > 100, pox in throat. On an unspecified date the patient recovered from her experiences. No further information is available.
Increased temperature on 12/13 and 12/14, up to 101.2, on 12/15 developed 2 cold sores, but no other lesions.  On 12/16, called office, advised to seek medical attention as she divulged that she has been taking long-term Acyclovir for herpetic eye disease control.  Did not seek medical care as she states that the fever resolved and the cold sores didn't completely develop.  Reports that on 12/22 she developed 2 chickenpox-type lesions on right torso/chest, then between 12/22 and 12/16, she developed a total of approximately 10 lesions disseminated across trunk, ear, neck and foot.  Lesions faded or scabbed by 1/5/15.
Chills; weakness; a little light headed; This is a spontaneous report from a contactable consumer. A 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration in the left arm on 22Jan2021 10:30 at a single dose for covid-19 immunization. The patient's medical history included covid-19 from an unknown date and unknown if ongoing (prior to vaccination). The patient did not the patient receive any other vaccines within 4 weeks prior to the COVID vaccine and did not received other vaccine in four weeks. Patient had no allergies to medications, food, and other products. On 22Jan2022 at 15:00, the patient experienced chills, weakness and a little light headed. The outcome of the event was recovered on an unknown date. The patient has not been tested for COVID-19 since the vaccination.   Information on the lot/batch number has been requested.
Pt recvd vax 25OCT91 & on 25OT91 a strep culture was noted to be pos for strep pharyngitis; 11NOV91 pt presented to MD dx w/erythema nodosum of the lower legs; MD felt pt's condition was not related to vax;
Pt seen in primary care clinic on 31 Oct 9 days following smallpox vaccine. Pt stated C/O right muscle pain (localized at injection site). At 10 day post vaccine appt., pt stated having SOB with chest palpitations.
This spontaneous report as received from a consumer refers to a patient of unknown age. The patient claimed to be immunocompromised. Medical history and concomitant medication was unknown. On an unknown date the patient was vaccinated with M-M-R II. Patient posted in social media as some kids are just born immuno-compromised like patient was. The outcome of the event is unknown. The relatedness of M-M-R II with the event was not reported. Despite being vaccinated, patient had measles and had to stop taking the flu vaccine because patient stayed sick constantly and still got the flu (linked MARRS ID 1404USA011719). Additional information has been requested.
One day after vaccines administered, developed seizures --> staring spells, unresponsiveness fled by post-ictal episode.  Admitted to hospital.  EEG verified sz activity L temporal area.
High fever 2 days Severe headache 2 days Diarrhea 1 day Nauseous 2 day Vomiting 2 days
rash on my legs, up past my knees,it's bad,it's a rash on my hands too; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on my legs, up past my knees,it's bad,it's a rash on my hands too) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Rash.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on my legs, up past my knees,it's bad,it's a rash on my hands too). At the time of the report, RASH (rash on my legs, up past my knees,it's bad,it's a rash on my hands too) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was not provided by the reporter. Treatment medication includes antibiotics.
Information has been received from a physician concerning a 64 inch, 92 pound, 24 year old, generally healthy, female, witness advocate, who on an unspecified date was vaccinated with the first dose of GARDASIL, in the left deltoid.  On 07-APR-2008 the patient was vaccinated with her second dose of GARDASIL, in the left deltoid, lot # 659965/1978U.  On 09-MAY-2008, the patient sought medical attention for a "sick visit", she complained of a bump in the left deltoid area at the site of the injection.  It was reported that the patients arm was very thin and the first and second shot were done in the deltoid of the left arm.  A magnetic resonance image was taken on an unspecified date and showed possible infective etiology.  The patient was treated with unspecified antibiotics.  At the time of reporting, the patient was still being treated.  Additional information has been requested.
Expired product used; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 03-MAR-2023) for prophylaxis.   On 08-MAR-2023, the patient received Kinrix. On 08-MAR-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired product used). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 08-MAR-2023 The reporter reported that a expired dose of Kinrix was administered to a 4 year old male patient.  At the time of reporting, the dose had not been repeated. The reporter consented to follow up. The patient received an expire dose of Kinrix, which led to expired vaccine used.
Patient reports immediate pain and burning with receiving injection.  Continues to experience pain and burning that is continuous almost 3 months later.  He has concerns that his injection was given interarticular rather than IM.